enGene Holdings Inc. (ENGN)
(Delayed Data from NSDQ)
$3.68 USD
+0.11 (3.08%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $3.71 +0.03 (0.82%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth B Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
enGene Holdings Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ENGN 3.68 +0.11(3.08%)
Will ENGN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ENGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ENGN
Best Momentum Stocks to Buy for February 19th
New Strong Buy Stocks for February 19th
ENGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
How Much Upside is Left in enGene Holdings Inc. (ENGN)? Wall Street Analysts Think 238.77%
enGene Holdings Inc. (ENGN) Upgraded to Strong Buy: Here's Why
Here's Why enGene Holdings Inc. (ENGN) is Poised for a Turnaround After Losing -16.9% in 4 Weeks
Other News for ENGN
enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | ENGN Stock News
enGene Announces Board and Leadership Appointments to Support Commercial Readiness | ENGN Stock News
enGene names Matthew Boyd CRO, Jill Buck CDO
Wells Fargo Reaffirms Their Buy Rating on enGene Holdings (ENGN)
FDA Grants RMAT Designation for enGene's Detalimogene, Enabling Potential for Expedited Review ...